Last reviewed · How we verify

NCT03282331: MORPHEIT

Lung MORphological Modifications Evaluated by Electrical Impedance Tomography During Preoxygenation for the Intubation of Hypoxemic Patients: Comparison of Standard Oxygenation, High Flow Nasal Oxygen Therapy, and NonInvasive Ventilation (MORPHEIT Study, an Ancillary Study of PREONIV Trial)

Status unknown NA Last updated 14 September 2017
What this trial tests

NA trial testing Standard oxygenation in Adult Patients in 30 participants. Status unknown.

Timeline
2 June 2016
Primary endpoint
1 September 2017
1 October 2017

Quick facts

Lead sponsorUniversity Hospital, Clermont-Ferrand
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Primary purposetreatment
Enrollment30
Start date2 June 2016
Primary completion1 September 2017
Estimated completion1 October 2017
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Clermont-Ferrand

Who can join

18 and older, any sex, with Adult Patients or Requiring Intubation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective, randomized clinical multicentric study, in ICU, during preoxygenation for the intubation of hypoxemic patients. Electrical impedance tomographic evaluation of lung morphology variations according to the preoxygenation technique : Comparison of Standard Oxygenation, High Flow Nasal Oxygen Therapy, and NonInvasive Ventilation

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Standard oxygenation

Trials testing the same drug.

Other recruiting trials for Adult Patients

Currently open trials in the same condition.

Other University Hospital, Clermont-Ferrand trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03282331.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing